Giovanni Filardo's guest appearances

Giovanni Filardo

Healthy by Nature Show

What is Public Health with Dr. Kee Chan

Fred Pescatore

Steven Gundry

Abby Kohut

Tom O’Bryan

Dana Cohen

Michael Collins

Simon Cheng

David Getoff

David Kennedy

Ignaz Semmelweis

Tom Russell

Jacob Teitelbaum

Alan Phillips

Frank King

Stuart Tomc

OwlTail

"Without data, all you have are opinions" - Dr. Giovanni Filardo, MPH, PhD  What do statistical models really tell us about the spread of the coronavirus (COVID19)?   In this episode, on April 9, 2020, I interviewed Dr. Filardo who went over our Frequently Asked Questions (FAQs) on the epidemiology of coronavirus (COVID19). He will share with us his latest statistical model and his recommendations on using data and evidence, and not your gut feeling, to make informed decisions. Dr. Giovanni Filardo is a public health expert and epidemiologist who has created statistical models to understand the spread of coronavirus (COVID19). He has over 15 years of work experience in epidemiology, health services research, and comparative effectiveness.  He has received over $35 million from different funding agencies including the NIH and he published over 160 manuscripts and presented at more than 30 conferences. He is currently a Clinical Professor of Health Services Research at Baylor University Waco and Research Associate Professor of Statistics II at Southern Methodist University in Texas. Dr. Giovanni Filardo earned his Master of Public Health (MPH) from Emory University and his PhD in Epidemiology with a concentration in cardiovascular disease from Yale University.    Frequently Asked Questions (FAQs):  1. Based on the President Trump most recent briefing, the model showed that even with mitigation, we could expect between 100,000 to 200,000 deaths. What factors are taken into account for that model?  2. Did we overestimated the number of deaths? 3. What is happening with the COVID19 in term of testing or the lack of testing? 4. Why was there a delay at the start? Why didn’t the CDC use the test from WHO? Why did CDC want to make their own three tests which turned out only two of three were working? 5. What are countries have done to contain and/or mitigate covid-19? 6. What are the differences in characteristics of covid-19 positives among countries? 7. What is the difference in mortality rates among countries? 8. What are the risk factors associated with mortality? 9.  Are all countries testing for COVID-19 using WHO guidelines? 10. Are all countries assessing mortalities for COVID-19 using WHO guidelines? 11. How many ventilators do we 'actually" need to care for COVID-19 patients? 12. What will happen after we reach the ‘peak’? 13. How can we use surveillance using serological testing to assess how many people has been infected? 14. What are possible treatment available given the high number of ongoing studies? 15. What is the likelihood that we can develop a vaccine for those people who were not infected? How soon? 16.  Would it be better that we all ‘get infected’ in low doses to develop immunity and thus, herd immunity? 17.  How long do you think we would need to ’stay-at-home”?  If you have public health topics or questions, please connect with me at keechanphd@gmail.com or visit the website: www.whatispublichealthpodcast.com and submit your question on the 'Contact Us' page.  Or leave a voice message on the https://anchor.fm/whatispublichealth Watch the Washington Post Questions/Answers (Q/A) with Dr. Giovanni Filardo on Youtube at https://youtu.be/SzoBV6kVWkA Follow Dr. Giovanni Filardo on Twitter @GioFila   ---   Send in a voice message: https://podcasters.spotify.com/pod/show/whatispublichealth/message Support this podcast: https://podcasters.spotify.com/pod/show/whatispublichealth/support

"Without data, all you have are opinions" - Dr. Giovanni Filardo, MPH, PhD  What do statistical models really tell us about the spread of the coronavirus (COVID19)?   In this episode, on April 9, 2020, I interviewed Dr. Filardo who went over our Frequently Asked Questions (FAQs) on the epidemiology of coronavirus (COVID19). He will share with us his latest statistical model and his recommendations on using data and evidence, and not your gut feeling, to make informed decisions. Dr. Giovanni Filardo is a public health expert and epidemiologist who has created statistical models to understand the spread of coronavirus (COVID19). He has over 15 years of work experience in epidemiology, health services research, and comparative effectiveness.  He has received over $35 million from different funding agencies including the NIH and he published over 160 manuscripts and presented at more than 30 conferences. He is currently a Clinical Professor of Health Services Research at Baylor University Waco and Research Associate Professor of Statistics II at Southern Methodist University in Texas. Dr. Giovanni Filardo earned his Master of Public Health (MPH) from Emory University and his PhD in Epidemiology with a concentration in cardiovascular disease from Yale University.    Frequently Asked Questions (FAQs):  1. Based on the President Trump most recent briefing, the model showed that even with mitigation, we could expect between 100,000 to 200,000 deaths. What factors are taken into account for that model?  2. Did we overestimated the number of deaths? 3. What is happening with the COVID19 in term of testing or the lack of testing? 4. Why was there a delay at the start? Why didn’t the CDC use the test from WHO? Why did CDC want to make their own three tests which turned out only two of three were working? 5. What are countries have done to contain and/or mitigate covid-19? 6. What are the differences in characteristics of covid-19 positives among countries? 7. What is the difference in mortality rates among countries? 8. What are the risk factors associated with mortality? 9.  Are all countries testing for COVID-19 using WHO guidelines? 10. Are all countries assessing mortalities for COVID-19 using WHO guidelines? 11. How many ventilators do we 'actually" need to care for COVID-19 patients? 12. What will happen after we reach the ‘peak’? 13. How can we use surveillance using serological testing to assess how many people has been infected? 14. What are possible treatment available given the high number of ongoing studies? 15. What is the likelihood that we can develop a vaccine for those people who were not infected? How soon? 16.  Would it be better that we all ‘get infected’ in low doses to develop immunity and thus, herd immunity? 17.  How long do you think we would need to ’stay-at-home”? If you have public health topics or questions, please connect with me at keechanphd@gmail.com or visit the website: <a href="http://www.whatispublichealthpodcast.com" rel="nofollow" target="_blank">www.whatispublichealthpodcast.com</a> and submit your question on the 'Contact Us' page.  Or leave a voice message on the <a href="https://anchor.fm/whatispublichealth" rel="nofollow" target="_blank">https://anchor.fm/whatispublichealth</a> Watch the Washington Post Questions/Answers (Q/A) with Dr. Giovanni Filardo on Youtube at <a href="https://youtu.be/SzoBV6kVWkA" rel="nofollow" target="_blank">https://youtu.be/SzoBV6kVWkA</a> Follow Dr. Giovanni Filardo on Twitter @GioFila  --- Send in a voice message: <a href="https://podcasters.spotify.com/pod/show/whatispublichealth/message" rel="nofollow" target="_blank">https://podcasters.spotify.com/pod/show/whatispublichealth/message</a> Support this podcast: <a href="https://podcasters.spotify.com/pod/show/whatispublichealth/support" rel="payment nofollow" target="_blank">https://podcasters.spotify.com/pod/show/whatispublichealth/support</a>

FAQs on the Epidemiology of 2019 Novel Coronavirus (COVID-19) with Epidemiologist Dr. Giovanni Filardo (Coronavirus COVID19 series) 

Dr Kotsanis

Brenda Swartz

HBN’s favorite physician, Constantine (Gus) Kotsanis, MD and his nurse, Michelle Lytal, RN, BSN, will be in the studio to discuss “apheresis”.  That is a process which removes toxic components (that contribute to disease) and pro-inflammatory proteins from blood. Apheresis. Then we will visit with Giovanni Filardo, PhD, MPH, the Director of the Epidemiology Department, Office of the Chief Quality Officer, Baylor Scott &amp; White Health (BSWH), Dallas, TX.  He is the principal investigator for the All of Us Research Program being conducted at BSWH that will be our topic. Last but far from least, a long time friend of mine from the industry, Brenda Swartz, will tell us about internal cleansing and its connections to weight loss and inflammation. She will have to talk fast because I also want her to cover what works for wrinkles, dark spots, and crepe skin.

HBN’s favorite physician, <a href="https://www.kotsanisinstitute.com/" rel="nofollow" target="_blank">Constantine (Gus) Kotsanis, MD</a> and his nurse, Michelle Lytal, RN, BSN, will be in the studio to discuss “apheresis”.  That is a process which removes toxic components (that contribute to disease) and pro-inflammatory proteins from blood. <a href="https://www.kotsanisinstitute.com/therapies-and-treatments/apheresis" rel="nofollow" target="_blank">Apheresis.</a> Then we will visit with Giovanni Filardo, PhD, MPH, the Director of the Epidemiology Department, Office of the Chief Quality Officer, Baylor Scott &amp; White Health (BSWH), Dallas, TX.  He is the principal investigator for the <a href="https://www.bswhealth.com/research/Pages/all-of-us-research-program.aspx" rel="nofollow" target="_blank">All of Us Research Program</a> being conducted at BSWH that will be our topic. Last but far from least, a long time friend of mine from the industry, <a href="http://bodydynamics.com/" rel="nofollow" target="_blank">Brenda Swartz</a>, will tell us about internal cleansing and its connections to weight loss and inflammation. She will have to talk fast because I also want her to cover what works for wrinkles, dark spots, and crepe skin.

August 25th, 2018 Dr Kotsanis, MD will discuss apheresis. Giovanni Filardo, PhD, MPH will discuss research conducted at BSWH that will be our topic. Then Brenda Swartz, on  internal cleansing